Primary hypothyroidism, central diabetes insipidus and growth hormone deficiency in multisystem Langerhans cell histiocytosis: a case report

被引:11
作者
Rami, B [1 ]
Schneider, U [1 ]
Wandl-Vergesslich, K [1 ]
Frisch, H [1 ]
Schober, E [1 ]
机构
[1] Univ Vienna, Childrens Hosp, Vienna, Austria
关键词
central diabetes insipidus; growth hormone deficiency; Langerhans cell histiocytosis; pituitary stalk thickening; primary hypothyroidism;
D O I
10.1080/08035259850158010
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We report on a girl with central diabetes insipidus, growth hormone deficiency and bone lesions in multisystem Langerhans cell histiocytosis. Thickening of the pituitary stalk was detected by magnetic resonance imaging, which progressed over the course of the disease. During the observation period she developed primary hypothyroidism, which might be due to the extremely rare involvement of the thyroid gland in this disease. The girl underwent chemotherapy, which led to a regression of the Langerhans cell histiocytosis-lesion, but the hormone deficiencies persisted and substitution had to be continued. Langerhans cell histiocytosis should be included in the differential diagnosis in cases with pituitary stalk thickening and additional hypothalamic/pituitary hormone deficiencies, and in cases of acquired primary hypothyroidism, with or without enlargement of the thyroid gland and ultrasound findings similar to thyroiditis.
引用
收藏
页码:112 / 114
页数:3
相关论文
共 15 条
[1]   ANTERIOR-PITUITARY FUNCTION AND COMPUTED-TOMOGRAPHY MAGNETIC-RESONANCE-IMAGING IN PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS AND DIABETES-INSIPIDUS [J].
BROADBENT, V ;
DUNGER, DB ;
YEOMANS, E ;
KENDALL, B .
MEDICAL AND PEDIATRIC ONCOLOGY, 1993, 21 (09) :649-654
[2]   ETOPOSIDE (VP16) IN THE TREATMENT OF MULTISYSTEM LANGERHANS CELL HISTIOCYTOSIS (HISTIOCYTOSIS-X) [J].
BROADBENT, V ;
PRITCHARD, J ;
YEOMANS, E .
MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (02) :97-100
[3]   LANGERHANS CELL HISTIOCYTOSIS IN CHILDHOOD - RESULTS FROM THE ITALIAN COOPERATIVE AIEOP-CNR-H.X 83 STUDY [J].
CECI, A ;
DETERLIZZI, M ;
COLELLA, R ;
LOIACONO, G ;
BALDUCCI, D ;
SURICO, G ;
CASTELLO, M ;
TESTI, AM ;
DEBERNARDI, B ;
INDOLFI, P ;
MACCHIA, P ;
MADON, E ;
MANCINI, A ;
ROSATI, D .
MEDICAL AND PEDIATRIC ONCOLOGY, 1993, 21 (04) :259-264
[4]  
DEMEOCQ F, 1982, ARCH FR PEDIATR, V39, P449
[5]   THE FREQUENCY AND NATURAL-HISTORY OF DIABETES-INSIPIDUS IN CHILDREN WITH LANGERHANS-CELL HISTIOCYTOSIS [J].
DUNGER, DB ;
BROADBENT, V ;
YEOMAN, E ;
SECKL, JR ;
LIGHTMAN, SL ;
GRANT, DB ;
PRITCHARD, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) :1157-1162
[6]  
FAVARA BE, 1987, LANCET, V1, P208
[7]   HISTIOCYTOSIS-X INVOLVING THE THYROID AND HYPOTHALAMUS [J].
GAINES, P ;
CHAN, JCN ;
COCKRAM, CS .
POSTGRADUATE MEDICAL JOURNAL, 1991, 67 (789) :680-682
[8]   DIABETES-INSIPIDUS IN LANGERHANS CELL HISTIOCYTOSIS - RESULTS FROM THE DAL-HX-83 STUDY [J].
GROIS, N ;
FLUCHERWOLFRAM, B ;
HEITGER, A ;
MOSTBECK, GH ;
HOFMANN, J ;
GADNER, H .
MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (04) :248-256
[9]  
GROIS N, 1994, BR J CANC S23, V70, P24
[10]   TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN WITH ETOPOSIDE [J].
ISHII, E ;
MATSUZAKI, A ;
OKAMURA, J ;
INOUE, T ;
KAJIWARA, M ;
UOZUMI, T ;
YOSHIDA, N ;
MIYAZAKI, S ;
MIYAKE, K ;
MATSUMOTO, T ;
TASAKA, H ;
UEDA, K .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (06) :515-517